Kenya and Tanzania joint project
Accelerating access to blood disorders care in Kenya and Tanzania
Project supported by a grant from Novo Nordisk Foundation
Partner institution
Kenya Haemophilia Association (KHA)
and
Muhimbili National Hospital in Tanzania
Represented by
Stella Rwezaula, Dr
Kibet Shikuku, Dr
Duration
3 years
Status
Execution
Objectives
- Improve access to blood disorders care infrastructure in both countries by establishing or strengthening 16 centres in 3rd and 4th level hospitals and making basic care available in all counties/regions of Kenya and Tanzania
- Increase diagnosis rate by equipping the centres and through awareness raising and screening activities (diagnosing 600 new people with haemophilia)
- Empower the national patient organisations
- Create or upgrade the national blood disorders registries
- Build strategic alliances and advocate for improved care
- Leverage the learning and experiences from both countries
Project updates
A year of advancing care for haemophilia and sickle cell disease
16 December 2021
Project partners mark one year of accelerating access to blood disorders care in Kenya and Tanzania with four days of meetings and a resolution for achieving greater impact together.
To read more click here.
Official launch event in Nairobi
3 December 2020
Ministry of Health representatives from both countries were among those attending the official launch in Nairobi of the NNHF Kenya-Tanzania joint project designed to improve access to care for people with haemophilia and sickle cell disease.
To read more click here.
Building together for better diagnosis and treatment
18 November 2020
People living with haematological disorders in Kenya and Tanzania are set to benefit from a new joint NNHF project designed to better tackle haemophilia and sickle cell disease through capacity building, advocacy and awareness creation.
To read more click here.
